These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33217135)

  • 21. Atypical hemolytic-uremic syndrome: recurrent phenotypic expression of a patient with MCP gene mutation combined with risk haplotypes.
    Marini SC; Gomes M; Guilherme R; Carda JP; Pinto CS; Fidalgo T; Ribeiro ML
    Blood Coagul Fibrinolysis; 2019 Mar; 30(2):68-70. PubMed ID: 30676336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.
    Schaefer F; Ardissino G; Ariceta G; Fakhouri F; Scully M; Isbel N; Lommelé Å; Kupelian V; Gasteyger C; Greenbaum LA; Johnson S; Ogawa M; Licht C; Vande Walle J; Frémeaux-Bacchi V;
    Kidney Int; 2018 Aug; 94(2):408-418. PubMed ID: 29907460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical hemolytic uremic syndrome recurrence after kidney transplantation.
    Matar D; Naqvi F; Racusen LC; Carter-Monroe N; Montgomery RA; Alachkar N
    Transplantation; 2014 Dec; 98(11):1205-12. PubMed ID: 24933457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
    Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
    J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
    Esparza-Gordillo J; Jorge EG; Garrido CA; Carreras L; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
    Mol Immunol; 2006 Apr; 43(11):1769-75. PubMed ID: 16386793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid Responsive Atypical Hemolytic Uremic Syndrome Triggered by Influenza B Infection.
    Mittal N; Hartemayer R; Jandeska S; Giordano L
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):e63-e67. PubMed ID: 29702545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical Hemolytic Uremic Syndrome After Kidney Transplantation: Lessons Learned From the Good, the Bad, and the Ugly. A Case Series With Literature Review.
    Fayek SA; Allam SR; Martinez E; Pan G; Dao A; Rofaiel G
    Transplant Proc; 2020; 52(1):146-152. PubMed ID: 31924403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical hemolytic and uremic syndrome due to C3 mutation in pancreatic islet transplantation: a case report.
    Bahougne T; Olagne J; Munch M; Braun-Parvez L; Chenard MP; Frémeaux-Bacchi V; Caillard S; Baltzinger P; Greget M; Kessler L; Moulin B
    BMC Nephrol; 2020 Sep; 21(1):405. PubMed ID: 32950058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.
    Fakhouri F; Fila M; Provôt F; Delmas Y; Barbet C; Châtelet V; Rafat C; Cailliez M; Hogan J; Servais A; Karras A; Makdassi R; Louillet F; Coindre JP; Rondeau E; Loirat C; Frémeaux-Bacchi V
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):50-59. PubMed ID: 27799617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report.
    Yamamoto T; Watarai Y; Futamura K; Okada M; Tsujita M; Hiramitsu T; Goto N; Narumi S; Takeda A; Kobayashi T
    Transplant Proc; 2017; 49(1):159-162. PubMed ID: 28104125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.
    Provaznikova D; Rittich S; Malina M; Seeman T; Marinov I; Riedl M; Hrachovinova I
    Pediatr Nephrol; 2012 Jan; 27(1):73-81. PubMed ID: 21706448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case report: Eculizumab plus obinutuzumab induction in a deceased donor kidney transplant recipient with DEAP-HUS.
    Favi E; Molinari P; Alfieri C; Castellano G; Ferraresso M; Cresseri D
    Front Immunol; 2022; 13():1073808. PubMed ID: 36591301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
    Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S
    Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis.
    Gonzalez Suarez ML; Thongprayoon C; Mao MA; Leeaphorn N; Bathini T; Cheungpasitporn W
    J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31252541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era.
    Avila Bernabeu AI; Cavero Escribano T; Cao Vilarino M
    Nephron; 2020; 144(11):537-549. PubMed ID: 32950988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome- a single center experience.
    Kant S; Bhalla A; Alasfar S; Alachkar N
    BMC Nephrol; 2020 May; 21(1):189. PubMed ID: 32434487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
    Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP
    Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compound Haplotype Variants in
    Furmańczyk-Zawiska A; Kubiak-Dydo A; Użarowska-Gąska E; Kotlarek-Łysakowska M; Salata K; Kolanowska M; Świerniak M; Gaj P; Leszczyńska B; Daniel M; Jażdżewski K; Durlik M; Wójcicka A
    J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33920896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.